Found: 2
Select item for more details and to access through your institution.
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 6, p. 859, doi. 10.1093/eurjpc/zwaa034
- By:
- Publication type:
- Article
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry.
- Published in:
- European Heart Journal, 2020, v. 41, n. 18, p. 1720, doi. 10.1093/eurheartj/ehaa006
- By:
- Publication type:
- Article